Announcements Trials

Browse Landscape

Phase

Phase 1 3 Phase 2 2 Phase 3 1 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cisplatin 13 Paclitaxel 11 Cyclophosphamide 11 Doxorubicin 10 Magnetic Resonance Spectroscopy 9 Prednisone 8 Gemcitabine 8 Docetaxel 8 Specimen Handling 7 Oxaliplatin 7 Carboplatin 7 Vincristine 6 Etoposide 6 Capecitabine 6 pembrolizumab 5 Rituximab 5 Radiotherapy 5 Leucovorin 5 Cytarabine 5 Bevacizumab 5 atezolizumab 4 Trastuzumab 4 Platinum 4 Nivolumab 4 Fluorouracil 4 Dexamethasone 4 Biopsy 4 1,2-diaminocyclohexaneplatinum II citrate 4 Watchful Waiting 3 Taxes 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Active not recruiting × inavolisib × Clear all

NCT04191499 2026-03-17

INAVO120

Hoffmann-La Roche

Phase 2/3 Active not recruiting

325 enrolled 14 charts 1 FDA

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡